Measuring stability to more effectively select therapeutic antibody candidates

This therapeutic antibody drug development webinar, discusses the idea of limiting the substantial investment of time, money, or resources. If you choose the right analytical tools to help make smarter decisions. We highlight why our Prometheus instrument using nanoDSF technology will help to make quantitative, data-driven solutions to help accelerate the therapeutic antibody drug development. Have a listen if you’re a curious scientist who loves learning about new technologies and how they can help make research more efficient!

Previous
Rapid and precise biosimilar candidate profiling by nanoDSF
Rapid and precise biosimilar candidate profiling by nanoDSF

Up next
Understanding unfolding and refolding of the antibody fragment (Fab). I. In-vitro study
Understanding unfolding and refolding of the antibody fragment (Fab). I. In-vitro study

Looking for the optimal formulation for your biologics candidates?

NanoTemper tools can help

Find out how